Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II trial evaluates pixantrone as part of BSHAP regimen for NHL

Oct. 24, 2003

Rolling NDA submission for clofarabine begins

Oct. 24, 2003

Long-term evaluation of anastrozole and tamoxifen in postmenopausal women with breast cancer

Oct. 24, 2003

Japanese researchers identify c-fos expression modulators for cancer therapy

Oct. 24, 2003

New inhibitors of FAK and other kinases developed at Aventis Pharma

Oct. 24, 2003

TaiGen and TTY Biopharm sign joint development, marketing agreement for DB-67

Oct. 24, 2003

Vion licenses Triapine rights in China, Taiwan, Hong Kong and Macao

Oct. 23, 2003

Novel protein kinase inhibitors identified by Vertex scientists

Oct. 23, 2003

Curacyte claims novel urokinase inhibitors with utility in cancer therapy

Oct. 23, 2003

Roche describes new AKT inhibitors as potential propapoptotic antitumor agents

Oct. 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...